FX Conferences is proud to be the leader in providing convenient distance learning opportunities designed for busy professionals. We partner with leading industry experts to bring you key information and guidance on the latest challenges and hot topics, and our audio conference format makes it easy to participate from the office, at home or on the road. Feel free to browse through our list of coming events, or use our search feature to review past live presentations now available as recordings.

Search By
Industry
Department

Companion Diagnostics - What Pharma Needs to Know About IVDs


Audio conference highlights


If you are contemplating a companion diagnostics program, or if you already have such a program in place, you need to live in both the drug and diagnostic worlds. One key component to securing FDA approval – and staying in compliance – is understanding how in vitro diagnostics are regulated. Is your test a 510(K) or a PMA? What is the difference between an LDT and an IVD? Does FDA care about ISO standards and certification? This audio conference presentation reviews the current regulatory landscape for IVD tests, as well as lab-developed tests and companion diagnostics, focusing on the things pharma companies need to know.


This audio conference covers:


  • IVD regulatory terminology pharma companies should know
  • The differences between FDA risk classifications
  • Aligning your drug and diagnostic development timelines
  • How the changing regulatory landscape can impact your product strategy


About the speaker:


David Kern, RAC MBA is Senior Director with Myraqa, a full-service IVD regulatory consulting firm. Dave has nearly 20 years of experience developing IVD and life science products. His experience in product development, project management, business development and relationship management grants him a wide view of the entire lifecycle management process. He has designed and implemented product development processes for both FDA and ISO environments, in both large and small companies. He also has extensive experience in creating and implementing governance structures to manage co-development and outsourcing relationships within both the IVD and therapeutics industries.


Dave holds a BS in Biochemistry from San Francisco State University, and an MBA from San Jose State University. He has extensive training in project management, facilitation and conflict resolution, and holds a Regulatory Affairs Certification.


Who should attend?


  • Regulatory Affairs Directors
  • Quality Directors
  • Clinical Affairs Directors
  • Development Directors
  • Project Management Directors
  • Marketing Directors
  • Business Development Directors


Product Details

David Kern, RAC MBA
Companion Diagnostics - What Pharma Needs to Know About IVDs
Title: Senior Director, Myraqa
Other Events: David Kern, RAC MBA
Duration: 60 minutes
Event Type: Previously recorded on 2011-04-20
Item #: ac20110420
20 Apr 2011 
Registration Price:
$249.00

Order Info

Select Order Type:  
Include Transcript With Order?:  
Quantity
More
Less
 
 
Bookmark and Share reviews

Reviews

Average Rating: (based on 1 review)

Showing 1 Review:

by G.D.
Document Specialist
The speaker is very knowledgable on the subject matter; however the delay was a bit an inconvenience to the audience.
Rate this item
© Copyright 2012
FXConferences.
All rights reserved.

FAQ  |  Medical Translation  |  Search  |  Privacy  |  Terms of Use  |  Contact